This company listing is no longer active
DSM-Firmenich Balance Sheet Health
Financial Health criteria checks 6/6
DSM-Firmenich has a total shareholder equity of €10.8B and total debt of €2.9B, which brings its debt-to-equity ratio to 26.6%. Its total assets and total liabilities are €17.4B and €6.6B respectively. DSM-Firmenich's EBIT is €652.0M making its interest coverage ratio 8. It has cash and short-term investments of €2.9B.
Key information
26.6%
Debt to equity ratio
€2.89b
Debt
| Interest coverage ratio | 8x |
| Cash | €2.88b |
| Equity | €10.85b |
| Total liabilities | €6.56b |
| Total assets | €17.40b |
Recent financial health updates
Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04
Financial Position Analysis
Short Term Liabilities: DSM's short term assets (€8.1B) exceed its short term liabilities (€2.6B).
Long Term Liabilities: DSM's short term assets (€8.1B) exceed its long term liabilities (€4.0B).
Debt to Equity History and Analysis
Debt Level: DSM's net debt to equity ratio (0.06%) is considered satisfactory.
Reducing Debt: DSM's debt to equity ratio has reduced from 37.4% to 26.6% over the past 5 years.
Debt Coverage: DSM's debt is well covered by operating cash flow (33.4%).
Interest Coverage: DSM's interest payments on its debt are well covered by EBIT (8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/31 16:43 |
| End of Day Share Price | 2023/05/30 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DSM-Firmenich AG is covered by 61 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mutlu Gundogan | ABN AMRO Bank N.V. |
| Martin Schnee | AlphaValue |
| Volker Bosse | Baader Helvea Equity Research |